• Publications
  • Influence
Cognitive function across manic or hypomanic, depressed, and euthymic states in bipolar disorder.
A poorer performance was observed in all bipolar groups regarding executive function and verbal memory in relation to the healthy comparison subjects, and cognitive difficulties, especially related to verbal memory, may help explain the impairment regarding daily functioning, even during remission. Expand
The HCL-32: towards a self-assessment tool for hypomanic symptoms in outpatients.
The performance of the scale in distinguishing individuals with BP from those with major depressive disorder and the HCL-32 distinguished between BP and MDD with a sensitivity of 80% and a specificity of 51%. Expand
Validity and reliability of the Functioning Assessment Short Test (FAST) in bipolar disorder
The FAST showed strong psychometrics properties and was able to detect differences between euthymic and acute BD patients, and is a short (6 minutes) simple interview-administered instrument, which is easy to apply and requires only a short period of time to apply. Expand
A randomized trial on the efficacy of group psychoeducation in the prophylaxis of recurrences in bipolar patients whose disease is in remission.
Group psychoeducation is an efficacious intervention to prevent recurrence in pharmacologically treated patients with bipolar I and II disorder. Expand
Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression.
Olanzapine is more effective than placebo, and combined olanzapine-fluoxetine isMore effective than olanZapine and placebo in the treatment of bipolar I depression without increased risk of developing manic symptoms. Expand
Cognitive impairment in euthymic bipolar patients: implications for clinical and functional outcome.
Evidence of neuropsychological impairment in euthymic bipolar patients is provided, after controlling for the effect of subsyndromal depressive symptoms, suggesting verbal memory and executive dysfunctions. Expand
Evidence-based guidelines for treating bipolar disorder: Revised third edition recommendations from the British Association for Psychopharmacology
The British Association for Psychopharmacology guidelines specify the scope and targets of treatment for bipolar disorder, and recommend strategies for the use of medicines in short-term treatment of episodes, relapse prevention and stopping treatment. Expand
Validation of the "World Health Organization Disability Assessment Schedule, WHODAS-2" in patients with chronic diseases
The latent structure originally designed by WHODAS-2 developers has been confirmed for the first time, and it has shown good metric properties in clinic and rehabilitation samples, and considerable support is provided to the WHODas-2 utilization as an international instrument to measure disability based on the ICF model. Expand
Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar
The Canadian Network for Mood and Anxiety Treatments (CANMAT) published guidelines for the management of bipolar disorder in 2005, with a 2007 update. This second update, in conjunction with theExpand
The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Update 2009 on the Treatment of Acute Mania
  • H. Grunze, E. Vieta, +5 authors WFSBP Task Force on Treatment Guidelines for Bipol
  • Medicine
  • The world journal of biological psychiatry : the…
  • 1 January 2009
These updated guidelines are based on a first edition that was published in 2003, and have been edited and updated with the available scientific evidence until end of 2008. Their purpose is to supplyExpand